PSTI

Pluristem Therapeutics Inc. PSTI

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PSTI MGTA RNTX EYEN STSA LUMO RENB GRNA CERC LIANY
6M -5.66 % -10.43 % -10.88 % 569.03 % 19.57 % 145.20 % -60.56 % -57.26 % 0.00 % -78.07 %
YTD 0.00 % 70.63 % -41.78 % -21.25 % 27.63 % 0.00 % -81.39 % -73.96 % 0.00 % -66.84 %
1Y -39.76 % -35.82 % -39.63 % -20.75 % -77.51 % 40.91 % -73.70 % -92.26 % -71.71 % -64.03 %
3Y -73.54 % -90.60 % -38.21 % -94.72 % -96.07 % -37.01 % -93.00 % -96.94 % -93.90 % -94.24 %
5Y -92.54 % -92.28 % -38.21 % -97.20 % -93.49 % 106.67 % -95.34 % -96.94 % -92.71 % -99.34 %
10Y -96.89 % -95.18 % -38.21 % -99.05 % -93.49 % -89.42 % -97.59 % -96.94 % -93.90 % -99.34 %
From the beginning -99.81 % -95.18 % -38.21 % -99.05 % -93.49 % -38.70 % -97.59 % -96.94 % -93.90 % -99.34 %

Dividend

Satsuma Pharmaceuticals, Inc.

LianBio